OpenAI made a series of announcements this week that emphasize its interest in bringing ChatGPT to patients and providers.
California, New Hampshire, Pennsylvania, and South Carolina stopped covering adult GLP-1 prescriptions for obesity on Jan. 1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback